These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 7953481)

  • 21. [Malignant pleural mesothelioma: early diagnosis and multimodality management].
    Pavia R; Mondello B; Barone M; Surleti S; Puliafito M; Barresi P
    G Chir; 2005; 26(6-7):257-60. PubMed ID: 16332304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant pleural mesothelioma.
    Knudsen N; Block K; Schulman S
    Oncol Nurs Forum; 1989; 16(6):845-51. PubMed ID: 2687807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignant pleural mesothelioma: current concepts in treatment.
    Tsiouris A; Walesby RK
    Nat Clin Pract Oncol; 2007 Jun; 4(6):344-52. PubMed ID: 17534390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphisms in DNA repair genes as risk factors for asbestos-related malignant mesothelioma in a general population study.
    Dianzani I; Gibello L; Biava A; Giordano M; Bertolotti M; Betti M; Ferrante D; Guarrera S; Betta GP; Mirabelli D; Matullo G; Magnani C
    Mutat Res; 2006 Jul; 599(1-2):124-34. PubMed ID: 16564556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Malignant pleural mesothelioma].
    Ploenes T; Osei-Agyemang T; Nestle U; Waller CF; Passlick B
    Dtsch Med Wochenschr; 2012 Mar; 137(10):481-6. PubMed ID: 22374657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding the impact of malignant mesothelioma.
    Gallacher R
    Nurs Times; 2004 Jul 27-Aug 2; 100(30):45. PubMed ID: 15338944
    [No Abstract]   [Full Text] [Related]  

  • 27. [Epidemiology, molecular biology, diagnostic and therapeutic strategy of malignant pleural mesothelioma in 2007 - an update].
    Porret E; Madelaine J; Galateau-Sallé F; Bergot E; Zalcman G
    Rev Mal Respir; 2007 Oct; 24(8 Pt 2):6S157-64. PubMed ID: 18235409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of asbestos in etiology of malignant pleural mesothelioma.
    Godleski JJ
    Thorac Surg Clin; 2004 Nov; 14(4):479-87. PubMed ID: 15559054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignant mesothelioma.
    Buesing-Fedorow JE
    Can Oncol Nurs J; 2002; 12(4):237-9. PubMed ID: 12518475
    [No Abstract]   [Full Text] [Related]  

  • 30. [Analysis of potential genetic risk factors for the development of malignant mesothelioma caused by asbestos exposure].
    Dianzani I; Gibello L; Biava A; Tamiazzo S; Bertolotti M; Mirabelli D; Magnani C
    Pathologica; 2003 Oct; 95(5):298-9. PubMed ID: 14989034
    [No Abstract]   [Full Text] [Related]  

  • 31. [Malignant pleural mesothelioma: causes, diagnosis and treatment].
    Bahm J; Knauf M; Bohndorf K
    Dtsch Med Wochenschr; 1990 Mar; 115(13):508-13. PubMed ID: 2180673
    [No Abstract]   [Full Text] [Related]  

  • 32. Recent advances in the molecular analysis of human malignant mesothelioma.
    De Rienzo A; Testa JR
    Clin Ter; 2000; 151(6):433-8. PubMed ID: 11211478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of malignant pleural mesothelioma.
    West SD; Lee YC
    Clin Chest Med; 2006 Jun; 27(2):335-54. PubMed ID: 16716822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishment of a human in vitro mesothelial cell model system for investigating mechanisms of asbestos-induced mesothelioma.
    Ke Y; Reddel RR; Gerwin BI; Reddel HK; Somers AN; McMenamin MG; LaVeck MA; Stahel RA; Lechner JF; Harris CC
    Am J Pathol; 1989 May; 134(5):979-91. PubMed ID: 2541616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Malignant mesothelioma of the pleura].
    Erika V; Zoltán S; Miklós Z; Judit A; Akos L; Kálmán K
    Orv Hetil; 1996 Feb; 137(5):233-8. PubMed ID: 8882441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesothelioma and asbestos-related pleural diseases.
    Greillier L; Astoul P
    Respiration; 2008; 76(1):1-15. PubMed ID: 18583923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of Bax and Fas ligand in erionite and asbestos induced Turkish malignant pleural mesothelioma.
    Kokturk N; Firat P; Akay H; Kadilar C; Ozturk C; Zorlu F; Gungen Y; Emri S
    Lung Cancer; 2005 Nov; 50(2):189-98. PubMed ID: 16043260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted therapies in malignant pleural mesothelioma: a review of clinical studies.
    Greillier L; Marco S; Barlesi F
    Anticancer Drugs; 2011 Mar; 22(3):199-205. PubMed ID: 21263312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in the systemic therapy of malignant pleural mesothelioma.
    Fennell DA; Gaudino G; O'Byrne KJ; Mutti L; van Meerbeeck J
    Nat Clin Pract Oncol; 2008 Mar; 5(3):136-47. PubMed ID: 18227828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current approach to malignant mesothelioma of the pleura.
    Aisner J
    Chest; 1995 Jun; 107(6 Suppl):332S-344S. PubMed ID: 7781415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.